Trade MerckCo USA ^MRK

Merck's Next Growth Chapter Is Starting to Outshine Keytruda Risk

Sectoral Asset Management Inc. Boosts Stake in Merck & Co., Inc. $MRK

Merck & Co., Inc. (MRK) Completes $6 Billion Public Offering of Notes

RHL Group LLC Makes New Investment in Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Shares Bought by Fisher Asset Management LLC

Choate Investment Advisors Buys 13,581 Shares of Merck & Co., Inc. $MRK

Genus Capital Management Inc. Takes Position in Merck & Co., Inc. $MRK

Legal & General Group Plc Has $2.08 Billion Stock Position in Merck & Co., Inc. $MRK - Daily Political

Choate Investment Advisors Has $10.37 Million Stake in Merck & Co., Inc. $MRK - Stock Observer

Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial

Mondrian Investment Partners LTD Sells 38,085 Shares of Merck & Co., Inc. $MRK - Zolmax

Mondrian Investment Partners LTD Sells 38,085 Shares of Merck & Co., Inc. $MRK - Daily Political

Prospera Financial Services Inc Purchases 6,991 Shares of Merck & Co., Inc. $MRK - Daily Political

Dividend Stocks To Consider - May 23rd - Stock Observer

Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints

Legato Capital Management LLC Purchases 8,759 Shares of Merck & Co., Inc. $MRK - Zolmax

Legato Capital Management LLC Buys 8,759 Shares of Merck & Co., Inc. $MRK

LSV Asset Management Cuts Stake in Merck & Co., Inc. $MRK

A Look at Merck & Co Inc (MRK) After 5.6% Gain -- GF Value $118.14 vs Price $122.41

Merck (MRK) and AbbVie (ABBV) Gain EU Panel Endorsements for New Treatments

Merck (MRK) Valuation Check After Key Oncology Trial Success And Positive EU Opinion

Merck (MRK) Advances Lung Cancer Treatment with New Drug Presentation

Merck & Co., Inc. $MRK Shares Bought by Pinnbrook Capital Management LP

Merck and Ecolab lead M&A funding charge

BioInvent Reveals Solid Data with its TNFR2 Antibody BI-1808 and KEYTRUDA(R) (pembrolizumab) in Advanced Ovarian Cancer at ASCO | Morningstar

Hepatitis A Market Research Report 2026-2036: Ecosystem, Marketed and Emerging Therapies, Epidemiological Analysis, Pipeline, Clinical Trial Landscape, Regulations Featuring GSK, Merck, and Sanofi

Oligometastatic Disease Market Analysis Report 2026-2036, Profiles of Leading Players - Dompe Farmaceutici, Bausch Health, Merck, Pfizer, and Glenmark Pharmaceuticals

Merck (MRK) - Expands Oncology Leadership with New Clinical Data at ASCO 2026

Griffin Asset Management Inc. Has $11.91 Million Stake in Merck & Co., Inc. $MRK - Zolmax

Eisai Deepens Body of Clinical Evidence for LENVIMA (Lenvatinib) Across Established Indications at ASCO 2026 | Morningstar

Lazard Freres Gestion S.A.S. Increases Stock Position in Merck & Co., Inc. $MRK - Zolmax

ProShare Advisors LLC Grows Stock Position in Merck & Co., Inc. $MRK - Zolmax

Banque Cantonale Vaudoise Acquires 5,765 Shares of Merck & Co., Inc. $MRK - Stock Observer

Lazard Freres Gestion S.A.S. Increases Stock Position in Merck & Co., Inc. $MRK - Daily Political

Merck & Co., Inc. $MRK Shares Sold by PNC Financial Services Group Inc. - Daily Political

Envestnet Portfolio Solutions Inc. Buys 12,461 Shares of Merck & Co., Inc. $MRK - Daily Political

Merck's Sacituzumab Tirumotecan Achieves Key Milestones in Cancer Treatment

Merck (MRK) Partners with Exelixis in Clinical Trial for Colorectal Cancer

Merck inks Keytruda supply pact to support Exelixis cancer trial

Sapient Capital LLC Takes Position in Merck & Co., Inc. $MRK - Stock Observer

Handelsbanken Fonder AB Boosts Stock Holdings in Merck & Co., Inc. $MRK

HighTower Advisors LLC Sells 50,990 Shares of Merck & Co., Inc. $MRK

Gabelli Funds LLC Cuts Holdings in Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Shares Acquired by Handelsbanken Fonder AB - Daily Political

Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Trials

Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T

Merck KGaA (OTCMKTS:MKGAF) and Evotec (OTCMKTS:EVTCY) Critical Contrast - Zolmax

Requisite Capital Management LLC Sells 9,626 Shares of Merck & Co., Inc. $MRK - Daily Political

L & S Advisors Inc Increases Stake in Merck & Co., Inc. $MRK

May Hill Capital LLC Increases Stock Holdings in Merck & Co., Inc. $MRK - Zolmax

Canada Post Corp Registered Pension Plan Increases Position in Merck & Co., Inc. $MRK - Zolmax

Financial Security Advisor Inc. Raises Holdings in Merck & Co., Inc. $MRK

Lockheed Martin Investment Management Co. Has $9.87 Million Stock Holdings in Merck & Co., Inc. $MRK - Zolmax

DNB Asset Management AS Increases Holdings in Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK Shares Acquired by Convergence Investment Partners LLC

Merck & Co., Inc. $MRK Shares Bought by Financial Security Advisor Inc. - Stock Observer

Merck & Co., Inc. $MRK Stake Reduced by ANTIPODES PARTNERS Ltd

Applied Finance Capital Management LLC Purchases 5,428 Shares of Merck & Co., Inc. $MRK - Daily Political

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial

Merck & Co., Inc. $MRK Stock Holdings Increased by Phoenix Financial Ltd.

Bessemer Group Inc. Increases Holdings in Merck & Co., Inc. $MRK

Merck & Co., Inc. $MRK is Conning Inc.'s 5th Largest Position

Allworth Financial LP Grows Stake in Merck & Co., Inc. $MRK

Thrivent Financial for Lutherans Raises Stock Holdings in Merck & Co., Inc. $MRK - Daily Political

Is Merck (MRK) Fairly Valued After Strong Long Term Returns And Mixed Intrinsic Value Signals

World Investment Advisors Buys 20,067 Shares of Merck & Co., Inc. $MRK

Bank Julius Baer & Co. Ltd Zurich Acquires 100,280 Shares of Merck & Co., Inc. $MRK - Stock Observer

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial

European Stocks Rise as Investors Focus on Earnings Reports

Merck & Co., Inc. $MRK Stake Lifted by Independent Advisor Alliance

Merck (MRK) Stock Surges 8% on Strong Q1 Results and Improved 2026 Outlook

Merck & Co., Inc. $MRK Shares Sold by Money Concepts Capital Corp

Independent Advisor Alliance Purchases 10,706 Shares of Merck & Co., Inc. $MRK - Stock Observer

Did Merck's (MRK) Upgraded 2026 Outlook and Keytruda Deals Just Redefine Its Investment Narrative? - Simply Wall St News

Analyst Reinstates Merck (MRK) with 'Neutral' Rating, $125 Price Target

BioInvent's TNFR2 Antibody BI-1808 Shows Strong Activity and Immune Activation as Single Agent and in Combination with KEYTRUDA(R) (pembrolizumab) in Advanced CTCL (EHA 2026) | Morningstar

5 Biggest Pharmaceutical ETFs for Investors in 2026

Merck (MRK) Partners with Erasca on Cancer Treatment Trial

Swiss Life Asset Management Ltd Raises Position in Merck & Co., Inc. $MRK

Merck's (NYSE:MRK) Soft Earnings Don't Show The Whole Picture - Simply Wall St News

Investors Can Find Comfort In Merck's (NYSE:MRK) Earnings Quality

Merck & Co., Inc. $MRK Shares Sold by ABN AMRO Bank N.V.

Merck & Co., Inc. $MRK Shares Sold by SVB Wealth LLC - Daily Political

Diversify Wealth Management LLC Sells 5,954 Shares of Merck & Co., Inc. $MRK - Stock Observer

10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen

Income Insurance Ltd Makes New $793,000 Investment in Merck & Co., Inc. $MRK

Osprey Private Wealth LLC Raises Stock Position in Merck & Co., Inc. $MRK

Midwest Trust Co Has $80.73 Million Stock Holdings in Merck & Co., Inc. $MRK - Daily Political

Wesbanco Bank Inc. Sells 17,179 Shares of Merck & Co., Inc. $MRK

Ethic Inc. Boosts Holdings in Merck & Co., Inc. $MRK

Farmers & Merchants Investments Inc. Decreases Position in Merck & Co., Inc. $MRK - Stock Observer

Crossmark Global Holdings Inc. Has $24.83 Million Stock Position in Merck & Co., Inc. $MRK - Daily Political

Merck & Co., Inc. (NYSE:MRK) Given Consensus Rating of "Moderate Buy" by Brokerages - Daily Political

3 Stocks That Could Be Trading Up To 46.1% Below Their Estimated Intrinsic Value

Navellier & Associates Inc. Trims Stock Position in Merck & Co., Inc. $MRK - Zolmax

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Eurozone inflation, Fed meeting, Apple earnings

Week ahead: Wall Street’s Magnificent Seven earnings are up

Week ahead: Fed, BoE to hold; Apple leads big tech earnings

Moderna share price jumps as Oppenheimer upgrades stock

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk